Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Anti-Siglec-2 / CD22 (NCI m972) For research use only.
Not for use in humans.

Anti-Siglec-2 / CD22 (NCI m972)

Synonyms: m972

Anti-Siglec-2 / CD22 (NCI m972) is a humanized monoclonal antibody targeting CD22, a Siglec family lectin present on B cells. It is a promising novel therapeutics for B-cell acute lymphoblastic leukemia (BCP-ALL). MW :144.3 KD.

Anti-Siglec-2 / CD22 (NCI m972)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Anti-Siglec-2 / CD22 (NCI m972) is a humanized monoclonal antibody targeting CD22, a Siglec family lectin present on B cells. It is a promising novel therapeutics for B-cell acute lymphoblastic leukemia (BCP-ALL). MW :144.3 KD.

Product Details

Isotype Human IgG1
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Anti-Siglec-2 / CD22 (NCI m972) | Anti-Siglec-2 / CD22 (NCI m972) supplier | purchase Anti-Siglec-2 / CD22 (NCI m972) | Anti-Siglec-2 / CD22 (NCI m972) cost | Anti-Siglec-2 / CD22 (NCI m972) manufacturer | order Anti-Siglec-2 / CD22 (NCI m972) | Anti-Siglec-2 / CD22 (NCI m972) distributor